Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

American Journal of Pathology

Volumn 159, Issue 3, 2001, Pages 817-824

  Urosevic, Mirjana ^a   Kurrer, Michael O ^b   Kamarashev, Jivko ^a   Mueller, Beatrix ^a   Weder, Walter ^b   Burg, Guenter ^a   Stahel, Rolf A ^b   Dummer, Reinhard ^a   Trojan, Andreas ^b,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Stadtspital Triemli Departement fur Innere Medizin Abteilung fur Gastroenterologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; HLA ANTIGEN CLASS 1; HLA G ANTIGEN; INTERLEUKIN 10; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; LUNG CARCINOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MEMBRANE BINDING; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 0034850150     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61756-7     Document Type: Article

References (50)

1. Production of interleukin-10 by human bronchogenic carcinoma
2. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer
3. Loss of HLA haplotype in lung cancer cell lines: Implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer
4. Production of interleukin-10 by alveolar macrophages from lung cancer patients
5. How tumors escape immune destruction and what we can do about it
6. Immune escape mechanisms in malignant melanoma
7. Selective MHC expression in tumours modulates adaptive and innate antitumour responses
8. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
9. HLA-G: A tolerance molecule from the major histocompatibility complex
10. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
11. Natural killer cell-mediated recognition of human trophoblast
12. The HLA-G gene is expressed at a low mRNA level in different human cells and tissues
13. The immunotolerance role of HLA-G
14. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells
15. Human leukocyte antigen-G: Immunotolerant major histocompatibility complex molecule in transplantation
16. Human leucocyte antigen-G and its recognition by natural killer cells
17. How do NK cells sense the expression of HLA-G class Ib molecules?
18. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
19. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules
20. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily
21. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes
22. Expression of HLA G in human tumors is not a frequent event
23. HLA-G protein expression is not induced during malignant transformation
24. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies
25. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
26. Modulation of HLA-G antigens expression in myelomonocytic cells
27. Lung carcinoma: Analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry
28. T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function
29. Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients
30. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
31. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression
32. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes
33. Implication of HLA-G molecule in heart-graft acceptance
34. Tolerance to the foeto-placental 'graft': Ten ways to support a child for nine months
35. Modulation of HLA-G antigens expression by human cytomegalovirus: Specific induction in activated macrophages harboring human cytomegalovirus infection
36. Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma
37. Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells
38. HLA-G transcription studies during the different stages of normal and malignant hematopoiesis
39. Posttranscriptional regulation of human leukocyte antigen G during human extravillous cytotrophoblast differentiation
40. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition
41. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis
42. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response
43. Cutting edge: Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8
44. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association
45. Nonclassical HLA-G molecules are classical peptide presenters
46. Cytokine biosynthesis by tumor-infiltrating T lymphocytes from human nonsmall-cell lung carcinoma
47. A deficiency of placental IL-10 in preeclampsia
48. Presence of HLA-G-expressing cells modulates the ability of peripheral blood mononuclear cells to release cytokines
49. Peripheral blood mononuclear cells from women with recurrent abortion exhibit an aberrant reaction to release cytokines upon the direct contact of human leukocyte antigen-G-expressing cells
50. Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood